Evidence map›Paper›PMID 14565978›Full record

ArticleMolecular biology of the cell2004

The dynamic association of RCC1 with chromatin is modulated by Ran-dependent nuclear transport.

Ian Cushman, David Stenoien, Mary Shannon Moore

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Ian CushmanInterdepartmental Program in Cell and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
David Stenoien
Mary Shannon Moore
Baylor College of Medicine · USInstitute of Molecular and Cell Biology · RU

Funding

Initiative for Maximizing Student Development (IMSD) ProgramR25GM056929 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI PEREIRA, FRED A · 1998 to 2023
$12.4M
TRAINING PROGRAM IN MOLECULAR ENDOCRINOLOGYT32DK007696 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI MOORE, DAVID D · 1993 to 2012
$2.8M
STUDIES OF MITOSIS IN NORMAL AND NEOPLASTIC CELLSR01CA041424 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRINKLEY, BILL R · 1985 to 2006
$2.3M
STUDIES OF MITOSIS IN NORMAL AND NEOPLASTIC CELLSR37CA041424 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRINKLEY, BILL R · 1988 to 1995
–
NCI NIH HHS CA 41424NCI NIH HHS R01 CA041424NIDDK NIH HHS DK07696NIDDK NIH HHS T32 DK007696NIGMS NIH HHS GM56929NIGMS NIH HHS R25 GM056929
6 · The paper itself

Abstract

Regulator of chromosome condensation (RCC1) binding to chromatin is highly dynamic, as determined by fluorescence recovery after photobleaching analysis of GFP-RCC1 in stably transfected tsBN2 cells. Microinjection of wild-type or Q69L Ran markedly slowed the mobility of GFP-RCC1, whereas T24N Ran (defective in nucleotide loading) decreased it further still. We found significant alterations in the mobility of intranuclear GFP-RCC1 after treatment with agents that disrupt different Ran-dependent nuclear export pathways. Leptomycin B, which inhibits Crm1/RanGTP-dependent nuclear export, significantly increased the mobility of RCC1 as did high levels of actinomycin D (to inhibit RNA polymerases I, II, and III) or alpha-amanitin (to inhibit RNA polymerases II and III) as well as energy depletion. Inhibition of just mRNA transcription, however, had no affect on GFP-RCC1 mobility consistent with mRNA export being a Ran-independent process. In permeabilized cells, cytosol and GTP were required for the efficient release of GFP-RCC1 from chromatin. Recombinant Ran would not substitute for cytosol, and high levels of supplemental Ran inhibited the cytosol-stimulated release. Thus, RCC1 release from chromatin in vitro requires a factor(s) distinct from, or in addition to, Ran and seems linked in vivo to the availability of Ran-dependent transport cargo.

Indexed as

Cell Cycle ProteinsNuclear ProteinsActive Transport, Cell NucleusAmanitinsAnimalsAntibiotics, AntineoplasticCells, CulturedChromatinCricetinaeCytosolDactinomycinFatty Acids, UnsaturatedGuanine Nucleotide Exchange FactorsGuanosine TriphosphateMicroinjectionsMicroscopy, FluorescenceAmanitinsAntibiotics, AntineoplasticCell Cycle ProteinsChromatinDactinomycinFatty Acids, UnsaturatedGuanine Nucleotide Exchange FactorsGuanosine Triphosphateleptomycin BNuclear ProteinsProtein Synthesis Inhibitorsran GTP-Binding ProteinRecombinant Fusion Proteins

Identifiers

PMID14565978
PMCPMC307544
OpenAlexW2150624635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.